FDA approves updated COVID boosters, but narrows use
While the agency cleared vaccines from Pfizer, Moderna and Novavax broadly in older adults, it restricted eligibility in younger people to those with underlying health conditions.
Previous Post
Beyond One-Size-Fits-All: A Guide to Precision Medicine and Personalized Healthcare
Next Post
Urine Proteomic Signatures of Kidney Function Decline after Hospitalization
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago